Clinical Trials

Phase 2 Not yet recruiting

48 enrolled

Head & Neck

Deglutition Disorders, Head and Neck Neoplasms

NCT07292207 2025-12-18

ARCHE

30 enrolled

Breast Neoplasms

NCT05559164 2025-11-14

Statins for Reduction of Cardiac Toxicity in Patients Receiving HER2 Targeted

60 enrolled

Breast Neoplasms, Cardiotoxicity

NCT05392608 2025-09-17

SEQUEL-Breast

130 enrolled

Breast Neoplasms, Genetic Diseases, Inborn

NCT06033092 2025-08-28

TOLERANT

200 enrolled

Breast Carcinoma In Situ, Carcinoma, Intraductal, Noninfiltrating

NCT06150898 2025-06-13

KePreSt

112 enrolled

BreastOther

Breast Neoplasms, Inflammation, Obesity

NCT05247268 2025-04-06

Gonadotropin-releasing Hormone Agonist (GnRHa) Plus Letrozole In Young Women With Early Endometrial Cancer

104 enrolled

Gynecologic

Endometrial Neoplasms

NCT02852486 2025-03-30

EDI-PIO

MyeloidOther hematologic neoplasm

31 enrolled

Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT04717700 2025-03-18

SABLe

50 enrolled

Plasma cell

Multiple Myeloma

NCT04722575 2025-03-13

NEO-TIM

95 enrolled

Melanoma

NCT06275919 2025-03-13

MIRAGE

104 enrolled

CNS

Meningioma

NCT04503694 2025-03-05

REGINA

72 enrolled

LymphoidOther hematologic neoplasm

Rectal Neoplasms

NCT04554459 2024-08-14

Pona-CELL

Phase 2 Terminated

4 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05163106 2024-08-02

NEOLETRIB

85 enrolled

Breast Neoplasms

NCT05265988 2024-07-31

MERIDIAN

32 enrolled

Genitourinary

Prostatic Neoplasms

NCT04243122 2024-05-29

AIRPORT-MPN

Classical hematologyMyeloid

44 enrolled

Myeloproliferative Disorders, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

NCT06229067 2024-01-29

Efficacy and Safety of PD-L1 Monoclonal Antibody Combined With Metronomic VEX in Advanced Triple-negative Breast Cancer

Phase 2 Not yet recruiting

182 enrolled

Breast Neoplasms, Triple Negative Breast Neoplasms

NCT05370807 2023-10-24

RegoMel

48 enrolled

Melanoma

NCT03086538 2022-06-15

Pemetrexed Plus Tarceva as Salvage Treatment in EGFR Overexpressed Metastatic Colorectal Cancer Patients Who Were Failed After Standard Chemotherapy

29 enrolled

Colonic Neoplasms

NCT02897050 2022-04-20

Trial of Neoadjuvant Docetaxel ± Metronomic Capecitabine/CTX Followed by FEC in Women With Operable Triple Negative Breast Cancer

Phase 2 Suspended

170 enrolled

Breast Neoplasms

NCT04369365 2022-04-07

A Single-blinded, Randomized, Placebo Controlled Phase II Trial of Prophylactic Treatment With Oral Azithromycin Versus Placebo in Cancer Patients Undergoing Antineoplastic Treatment During the Corona Virus Disease 19 (COVID-19) Pandemic

74 enrolled

COVID

NCT04389073 2022-02-25

Safety and Efficacy of Toripalimab in HER2- Metastatic Breast Cancer Patients Treated With Metronomic Vinorelbine

138 enrolled

Breast Neoplasms

NCT02045017 2021-08-27

Efficacy and Safety of Pomalidomide and Dexamethasone in RRMM Patients With Renal Insufficiency

81 enrolled

Plasma cell

Multiple Myeloma, Renal Insufficiency

NCT03448731 2020-04-08

DERMIA

34 enrolled

Skin Toxicity

NCT04242927 2020-04-01

A Study to Investigate Nicotinic Acid on VEGFR Inhibitor-Associated Hand-Foot Skin Reactions

36 enrolled

Hand-Foot Skin Reaction (HFSR)

NCT03159845 2020-01-07

ZENITH

20 enrolled

Stem Cell Transplant Complications

NCT03024580 2019-08-15

MEGA

20 enrolled

Breast Neoplasms

NCT03405168 2018-11-16

Routine Therapy Plus Moxifloxacin in Advanced Breast Cancer

35 enrolled

Advanced Breast Cancer

NCT03259919 2018-10-18

pilPregMet

40 enrolled

Polycystic Ovary Syndrome

NCT02978547 2018-01-18

Metformin 001

20 enrolled

Resectable Pancreatic Ductal Adenocarcinoma

NCT01943864 2017-05-31

A Phase IIa Study of the MEK Inhibitor Trametinib Monotherapy in the Treatment of Biliary Tract Cancers

20 enrolled 27 charts

Biliary Tract Neoplasms, Neoplasms

NCT02756663 2016-11-08

PANORAMA-5

Phase 2 Withdrawn

Plasma cell

Multiple Myeloma, Recurrence

NCT01563055 2015-08-10

A Phase I/II, Open-label Study of Ofatumumab Added to Chlorambucil in Previously Untreated Japanese Patients With Chronic Lymphocytic Leukemia

LymphoidOther hematologic neoplasm

10 enrolled 52 charts

Leukemia, B-Cell

NCT01808326 2015-06-22

A Phase II, Open Label, Single Arm, Multicenter Study of Chlorambucil in Japanese Previously Untreated Patients With Chronic Lymphocytic Leukemia

Other hematologic neoplasm

5 enrolled 23 charts

Leukemia

NCT00086203 2015-03-25

Study of Talabostat and Rituximab in Advanced Chronic Lymphocytic Leukemia (CLL)

LymphoidOther hematologic neoplasm

Leukemia, Lymphocytic, Chronic, B-Cell

NCT00080080 2007-06-08

Study of Talabostat and Docetaxel in Advanced Non-Small Cell Lung Cancer

Thoracic

Lung Neoplasms

NCT00083239 2007-06-08

Study of Talabostat in Advanced Melanoma

Melanoma, Skin Neoplasms

NCT00083252 2007-06-08

Study of Talabostat and Cisplatin in Advanced Melanoma